Skip to content

Study of BGB-11417 in Patients with Mature B Cell Malignancies

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-515592-35-00
Acronym
BGB-11417-101
Enrollment
69
Registered
2024-10-10
Start date
2021-06-14
Completion date
Unknown
Last updated
2025-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mature B Cell Malignancies

Interventions

None listed

Sponsors

BeOne Medicines AG
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Countries

Italy, Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026